Baron & Budd is no longer accepting inquiries for this litigation. For an updated list of our current cases, visit our homepage. Updated: December 14, 2016
A Substantial Risk
The FDA warns that use of Abilify, the brand name of the drug aripiprazole, can lead to not only an uncontrollable urge to gamble but also several other impulse control problems. According to the warning, there have been many reports of people who experienced these issues only to see their urges disappear completely after discontinuing their use of the drug.
Abilify is used to treat several mental conditions, including Tourette’s syndrome, schizophrenia and bipolar disorder. In some instances it is used in combination with another anti-depressant. According to the FDA warning, Abilify can decrease symptoms such as disorganized thinking as well as hallucinations.
However, the FDA recommends that doctors and other healthcare providers inform patients about the risk of impulse control issues associated with Abilify, and ask patients currently on the drug whether or not they are experiencing uncontrollable urges. Anyone who is taking the drug should first talk to his or her doctor before discontinuing use, according to the FDA.
According to the agency’s statement, the FDA is now requiring that the risk of compulsive behavior be added to aripiprazole’s warning labels.
Know Your Rights
Unfortunately, many people have suffered substantial gambling losses after taking Abilify. These patients had no idea the drug could lead to this type of destructive behavior. If you experienced this problem, you may be able to take legal action against the manufacturer. Please contact Baron & Budd as soon as you can to learn more about your potential options. Give us a call at 866-520-2755 or complete our contact form to contact us online.